Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP 320 mg/25 mg tablets, USP, 90-count bottle, Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054. NDC 0591-2318-19.

D-0985-2018

July 16, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 80538
Status
Ongoing
Classification
Class II
Quantity
164,922 bottles
Official record key
drug-enforcement:D-0985-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lot Numbers: 1191188M, 1191189M, 1191190M, 1199220M, 1217576M, 1217577M, 1217578M, 1220832M, 1220833M, 1247283M, 1247284M, 1247285M, 1247286M, 1247287A, 1280632M, 1280633M

Distribution pattern: Product was distributed throughout the United States, including Hawaii and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations